Peripheral T-Cell Lymphomas (PTCL) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The Peripheral T-Cell Lymphomas (PTCL) clinical trial market research report provides an overview and top-line data relating to the clinical trials on PTCL. The report includes an overview of trials count and their average enrollment in top countries conducted globally. It also includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status, and sponsor type. The report also provides prominent drug names and trial counts for in-progress trials (based on the number of ongoing trials).
PTCL Clinical Trials Market Distribution by Regions and Countries
The top regions in the Peripheral T-Cell Lymphomas clinical trials market are North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America. Most of the clinical trials were conducted in North America.
In the country-wise analysis, the US has the highest number of peripheral t-cell lymphomas clinical trials, as of September 2022. Germany has the highest average patient enrollment in peripheral t-cell lymphoma clinical trials, as of September 2022.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, Italy has the highest proportion of PTCL in Oncology clinical trials as of September 2022.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, China has the highest proportion of PTCL in Oncology clinical trials as of September 2022.
PTCL Clinical Trials Market Analysis, By Regions
For more regional insights on PTCL clinical trials market, download a free report sample
PTCL Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the PTCL clinical trials market are the institution, company, and government. Out of them, the institution segment dominates the market.
PTCL Clinical Trials Market Analysis, by Sponsor Types
To know more about key sponsor types in PTCL clinical trials market, download a free report sample
Competitive Landscape
The leading companies in the PTCL clinical trials market are Bristol-Myers Squibb Co, Takeda Pharmaceutical Co Ltd, Seagen Inc, CSPC Pharmaceutical Group Ltd, Mundipharma International Ltd, Merck & Co Inc, Bayer AG, Shenzhen Chipscreen Biosciences Co Ltd, Sanofi, and Johnson & Johnson. Bristol-Myers Squibb Co sponsored the highest number of PTCL clinical trials.
PTCL Clinical Trials Market Analysis, by Leading Companies
To know more about leading companies in the PTCL clinical trials market, download a free report sample
PTCL Clinical Trials Market Report Overview
Key Regions | North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America |
Key Countries | The US, China, Italy, France, Japan, South Korea, United Kingdom, Canada, Germany, and Spain |
Key Sponsor Types | Institution, Company, and Government |
Leading Companies | Bristol-Myers Squibb Co, Takeda Pharmaceutical Co Ltd, Seagen Inc, CSPC Pharmaceutical Group Ltd, Mundipharma International Ltd, Merck & Co Inc, Bayer AG, Shenzhen Chipscreen Biosciences Co Ltd, Sanofi, and Johnson & Johnson |
Scope
The report provides:
- A snapshot of the global clinical trials landscape
- Top level data related to the clinical trials by region, country, trial status, trial phase, sponsor type, and end point status
- Reviews of top companies involved and enlists all trials pertaining to the company
- All the unaccomplished trials with the reason for unaccomplishment
- Enrollment trends for the past five years
- Latest news for the past three months
Reasons to Buy
- Assists in formulating key business strategies with regard to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top-level analysis of the global clinical trials market which helps in identifying key business opportunities
- Supports understanding of trial count and enrollment trends by country in the global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted trials
- Facilitates clinical trial assessment of the indication on a global, regional, and country level
Takeda Pharmaceutical Co Ltd
Seagen Inc
CSPC Pharmaceutical Group Ltd
Merck & Co Inc
Mundipharma International Ltd
Bayer AG
Johnson & Johnson
Sanofi
Shenzhen Chipscreen Biosciences Co Ltd
Table of Contents
Frequently asked questions
-
What are the key regions in the PTCL clinical trials market?
The top regions in the PTCL clinical trials market are North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America.
-
What are the key countries in the PTCL clinical trials market?
The top countries in the PTCL clinical trials market are the US, China, Italy, France, Japan, South Korea, the United Kingdom, Canada, Germany, and Spain.
-
What are the key sponsor types in the PTCL clinical trials market?
Institutions, companies, and governments are the key sponsor types in the PTCL clinical trials market.
-
Which are the leading companies in the PTCL clinical trials market?
The leading companies in the PTCL clinical trials market are Bristol-Myers Squibb Co, Takeda Pharmaceutical Co Ltd, Seagen Inc, CSPC Pharmaceutical Group Ltd, Mundipharma International Ltd, Merck & Co Inc, Bayer AG, Shenzhen Chipscreen Biosciences Co Ltd, Sanofi, and Johnson & Johnson.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Oncology reports
